Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-22

Clinical Trial Update: Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost [Phase 4]

View source ↗

Summary

A Phase 4 trial compared netarsudil to brimonidine in normal tension glaucoma patients who are on latanoprost to evaluate comparative intraocular pressure contr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALPHAGAN P (BRIMONIDINE TARTRATE)
  • RHOPRESSA (NETARSUDIL)
  • Xalatan (latanoprost)

Snippet

Sponsor: Westlake Eye Specialists | Conditions: Normal Tension Glaucoma | Phase 4 | Status: COMPLETED